TNXEarnings•globenewswire•
Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights
Sentiment:Positive (70)
Summary
FDA PDUFA goal date of August 15, 2025, for TNX‑102 SL for fibromyalgia: if approved by FDA, TNX‑102 SL would be the first new drug for fibromyalgia in more than 16 years
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 11, 2025 by globenewswire